오픈뉴스백과
세계의 오늘
관련 뉴스7건5개 미디어
정치
보수 성향

First-of-its-kind flu vaccine could be coming as FDA panel weighs historic shot

New York Post
조회 0
First-of-its-kind flu vaccine could be coming as FDA panel weighs historic shot

Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older.

The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu season. ...

전문 보기

이 뉴스, 독자들은 어떻게 느꼈나요?

첫 반응을 남겨보세요

로그인하면 감정 반응에 참여할 수 있어요.

공식 발표 ↔ 진영별 보도

진보 성향 25%중도 성향 50%보수 성향 25%
1건2건1건
공식 발표 (3건) — 공공 라이선스 원문 직접 열람
🇺🇸Federal Register Notices

Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals

🇺🇸Federal Register Notices

SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams

🇺🇸Federal Register Notices

Advisory Committee; Science Board to the Food and Drug Administration; Renewal

진보 성향1
🇬🇧The Guardian World

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

중도 성향2
🇨🇦CityNews Toronto

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

🇺🇸The Hill

FDA vaccine panel set to review Moderna mRNA flu shot

보수 성향1
🇺🇸New York Post
보는 중

First-of-its-kind flu vaccine could be coming as FDA panel weighs historic shot

관련 뉴스 제보는 로그인 후 가능합니다.